Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on CRANEWARE PLC. We currently have 18 research reports from 3 professional analysts.
|17Jan17 07:00||RNS||Trading Update|
|11Nov16 04:46||RNS||Dividend Currency Election|
|11Nov16 03:03||RNS||Total Voting Rights|
|11Nov16 12:06||RNS||Block listing Interim Review|
|08Nov16 06:08||RNS||Result of AGM|
|08Nov16 07:00||RNS||AGM Statement|
|31Oct16 05:03||RNS||Posting of Annual Report and Notice of AGM|
Frequency of research reports
Research reports on
N+1 Singer - Pharma & Biotech - Reflections on the UK sector post the US election
11 Nov 16
Although the performance of UK-listed Big Pharmas is closely linked to changing US market dynamics, the impact on our UK smallcap life science universe will likely be more muted given its early-stage nature. Nevertheless, potential changes to drug pricing and healthcare provision resulting from the likely reversal of the Affordable Care Act (Obamacare) could impact a number of companies in our universe. We highlight Summit Therapeutics (Corporate), ReNeuron (Buy), Vectura (Buy), Verona Pharma (Corporate) and Futura Medical (Corporate) as potential beneficiaries of a less adverse pricing environment, whilst Craneware (Hold) and AMS (Hold) could be negatively affected by potential US hospital spending delays.
N+1 Singer - Morning Song 11-11-2016
11 Nov 16
ADVANCED MEDICAL SOLUTIONS GROUP (AMS LN) | CRANEWARE PLC (CRW LN) | FUTURA MEDICAL (FUM LN) | HALFORDS GROUP (HFD LN) | PROACTIS HLDGS (PHD LN) | RENEURON GROUP (RENE LN) | SUMMIT THERAPEUTICS PLC (SUMM LN) | SWALLOWFIELD (SWL LN) | VECTURA GROUP (VEC LN) | VERONA PHARMA PLC (VRP LN)
N+1 Singer - Craneware - Safe haven with positive momentum
07 Jul 16
A positive year end update and ongoing strong order intake has prompted us to upgrade our EPS forecasts by 4%, moving towards management’s medium term ambition to get back to 20%+ growth. In addition, CRW is a dollar reporter and not exposed to any Brexit related uncertainties. We therefore see it as a key safe haven play with improving growth credentials and reiterate our Buy recommendation with an increased target price of 1033p (from 884p).
N+1 Singer - Technology SECTOR - Screening for Tech Ideas – a different approach
21 Jun 16
Whilst the majority of our work consists of the research we provide on individual companies and their respective investment cases, we thought it would be an interesting exercise to provide various screens of UK quoted technology companies using only their historical reported accounts. Whilst past performance is not always a good predictor of future performance, the track record of a business and ongoing momentum should be part of any investment analysis. We believe this note can provide a good starting point/short list for investors, catering to their different investment styles – whether their preference is growth, income (cash generation) or a mix of both. From this point, further investigation can be made on the respective investment cases of these companies.
N+1 Singer - Morning Song 21-06-2016
21 Jun 16
AMINO TECHNOLOGIES (AMO LN) | CRANEWARE PLC (CRW LN) | DIALIGHT (DIA LN) | DOTDIGITAL GROUP PLC (DOTD LN) | ECKOH PLC (ECK LN) | EMIS GROUP PLC (EMIS LN) | FIRST DERIVATIVES PLC (FDP LN) | FUTURA MEDICAL (FUM LN) | IDOX (IDOX LN) | IOMART GROUP (IOM LN) | IQE PLC (IQE LN) | NCC GROUP (NCC LN) | OMG (OMG LN) | SDL (SDL LN) | SENIOR PLC (SNR LN) | SERVELEC GROUP PLC (SERV LN) | SPIRENT COMMUNICATIONS (SPT LN) | SUMMIT THERAPEUTICS PLC (SUMM LN) | TRIBAL GROUP (TRB LN) | VECTURA GROUP (VEC LN)
Making Mobiles Better
17 Jan 17
Mobile phones are increasingly the key connection for the modern world. This means that the performance of mobile phones, and their networks, is going to become more critical for all the apps and businesses that rely on them. New technologies such as VR, AR, and AV will need better, more reliable connections to really move into the mainstream. In this thematic piece we attempt to identify some of the most important issues facing mobile phone networks and their users, and start to identify solutions and enablers that will solve these problems and create value by doing so.
Panmure Morning Note 18-01-2017
18 Jan 17
Blancco technology, a leading provider of data erasure solutions and mobile device diagnostics, has announced that its underlying profits are ahead of expectations. Organic sales growth remains strong, the group continues to win larger ticket orders and the mobile diagnostics is performing ahead of plan. Consequently, we are raising our FY17 PBT forecast from £8.0m to £8.3m.
N+1 Singer - NCC Group - Interims confirm underlying business sound
19 Jan 17
NCC’s interim results were largely flagged in the detailed trading update released in December. Group revenue increased 35% to £125.8 (organic growth +18%) and adj. EBITDA grew 15% to £21.3m. The group’s issues relating to contract losses/deferrals in the period were previously announced and are already included in our forecasts. The group has maintained its interim dividend at 1.5p, which we believe is an indication of the strong underlying business. Separately, NCC has announced that Paul Mitchell intends to step down as chairman in May ’17. We continue to believe that NCC remains a highly attractive asset in an area seeing strong structural growth and see the current share price weakness as an opportunity. We retain our Buy recommendation and 233p target price.
N+1 Singer - dotDigital Group - Trading update
17 Jan 17
dotDigital issued a trading update for the six months ended 31 December 2016, indicating revenue growth up 17% y-o-y to £15.0m with EBITDA in line with market expectations and on track for the full year. Cash has grown to £18.9m. Revenue was slightly light of expectations owing to a slower start in the US but Q2 already showed improvement with a strong pipeline building. Our EBITDA and EPS forecasts are unchanged but revenues trimmed by 4% for both years. There is much activity in broadening avenues of growth in terms of new connectors, partnerships and geographical footprint and we remain positive of its prospects. Interim results will be released on Feb 21.
Small Cap Breakfast
17 Jan 17
Global Energy Development (GED.L) — To be renamed Nautilus Marine Services. Schedule 1 from developer and seller of hydrocarbons and related products. Reverse takeover. Raising $10.5m via a convertible. Expected 9 Feb. Eco (Atlantic) Oil & Gas—TSX-V listed oil and gas exploration has announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise. Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January.